Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
NASDAQ:PMD
Price:
2.54 USD
0.4%
Market Closed
Updated:
May 9, 2024
Psychemedics Corp
Cost of Revenue
|
Psychemedics Corp
Cost of Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Psychemedics Corp
NASDAQ:PMD
|
Cost of Revenue
-$13.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-2%
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$307.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$180.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
See Also
What is Psychemedics Corp's Cost of Revenue?
Cost of Revenue
-13.7m
USD
-13.7m
USD
Based on the financial report for Dec 31, 2023, Psychemedics Corp's Cost of Revenue amounts to -13.7m USD.
What is Psychemedics Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
-2%
Over the last year, the Cost of Revenue growth was 14%. The average annual Cost of Revenue growth rates for Psychemedics Corp have been 6% over the past three years , 9% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
